Walker S, Levy T, Rex S, Paul V E
Department of Cardiology, Harefield Hospital, Uxbridge, Middlesex, UK.
Europace. 1999 Jul;1(3):206-9. doi: 10.1053/eupc.1999.0042.
We report a case of fully transvenous single-unit biventricular implantable cardioverter defibrillator (ICD) use in a 43-year-old woman with a manifesting carrier form of muscular dystrophy (Emery-Dreifuss syndrome). The indication for biventricular ICD use was progressive heart failure with ventricular arrhythmia, permanent atrial fibrillation and previous VVIR pacemaker insertion. Single-unit transvenous biventricular ICD implantation was undertaken without complication. No potentially serious device malfunction was noted during subsequent follow-up. We conclude that single-unit biventricular ICD implantation is feasible for pacing and ventricular tachyarrhythmia control in patients with underlying atrial fibrillation.
我们报告了一例43岁患有显性携带者型肌营养不良（埃默里-德赖富斯综合征）的女性患者使用完全经静脉单腔双心室植入式心脏复律除颤器（ICD）的病例。双心室ICD的使用指征为伴有室性心律失常、永久性心房颤动和既往VVIR起搏器植入史的进行性心力衰竭。进行了单腔经静脉双心室ICD植入，无并发症发生。在随后的随访中未发现潜在的严重设备故障。我们得出结论，对于合并潜在心房颤动的患者，单腔双心室ICD植入在起搏和控制室性快速心律失常方面是可行的。
